Clinical Trial

UPLYFT For Lymphoma Survivors

Completed
View on ClinicalTrials.gov →
Summary
The main purpose of this study is to field test and pilot an intervention called UPLYFT (Understand and Prevail: Lymphoma Fear of Recurrence Therapy) that includes information about lymphoma survivorship and tools to improve quality of life and reduce lymphoma-related worries among lymphoma survivors.
Protocol Amendment History 3 changes
critical Trial completed 2026-08-05
notable Primary completion pushed: 2026-05-31 -> 2026-07-17 2026-08-05
minor Completion moved earlier: 2026-08-31 -> 2026-07-17 2026-08-05
Trial Details
NCT Number NCT05080166
Lead Sponsor Dana-Farber Cancer Institute
Collaborators: American Society of Hematology
Conditions Lymphoma, Survivorship
Enrollment 74 participants
Start Date 2022-02-08
Primary Completion 2026-07-17 (estimated)
Study Completion 2026-07-17 (estimated)
Updated on ClinicalTrials.gov 2026-08-04